← FDA Drug Approvals (Drugs@FDA)
EVEROLIMUS
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HIKMA · Approved 2021-11-23
Drug application
- FDA Application #
ANDA207486- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- EVEROLIMUS
- Generic name
- EVEROLIMUS
- Active ingredients
- EVEROLIMUS
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- HIKMA
- Manufacturer
- Hikma Pharmaceuticals USA Inc.
- First approval
- 2021-11-23
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown